Hannah Joseph Hospital IPO

About Hannah Joseph Hospital Company

Hannah Joseph Hospital Limited, established in 2008 as a center of excellence for neurosurgery, neurology, psychiatry, and trauma care in Madurai, Tamil Nadu, India, was formally incorporated as a private limited company on October 24, 2011, and converted to public limited status in 2022. Starting as a 40-bed facility with twin operation theaters and a 17-bed ICU, the hospital evolved by expanding infrastructure to a 150-bed campus near Madurai airport in 2020, incorporating advanced cardiac sciences with cath lab and cardiac OT capabilities in response to patient needs for integrated neuro-cardiac care, alongside orthopedics, traumatology, and neuroimaging. Its core business focuses on specialized healthcare delivery in neurosciences and multispecialty services, with primary segments including complex neurosurgeries, interventional cardiology, open-heart procedures, stroke management, and trauma care supported by hybrid neuro-cardiac cath lab, 1.5 Tesla MRI, and cutting-edge surgical technologies. Key expertise encompasses high-caliber neurosurgical interventions, cardiac angioplasty, and comprehensive patient management under founder Dr. M.J. Arunkumar's leadership, leveraging state-of-the-art facilities for south Tamil Nadu. Unique strengths include a seamless ecosystem for neurosciences and trauma with ultra-modern infrastructure fostering growth in complex procedures and patient volumes. The hospital engages patients through an operational philosophy rooted in excellence, visionary infrastructure development, and commitment to international standards in neurological care to meet regional healthcare demands.